News

Is Europe really moving away from medical cannabis flower, and what does that mean for the future of the industry? In the latest Business of Cannabis  article, emerging European regulatory trends show new markets like Spain  and France  favouring CE-certified medical devices and alternative formats  over traditional dried flower. 🇪🇺🌿 Our CEO, Benjamin Jeanroy , offers an insightful perspective on this shift: France has struck a creative compromise  by allowing dried flower

We’re excited to share that Augur Associates  was recently featured on The GCS LAB Podcast , hosted by Christopher Tasker  of Global Cannabinoid Solutions (GCS) , a platform focused on science-led cannabis strategy and policy insights. In this episode, titled “Leading the Next Phase of French Cannabis with Industry Leaders Augur Associates” , Benjamin-Alexandre Jeanroy and Aurélien Bernard join the discussion to unpack the real dynamics shaping France’s emerging medical cann

After months of political uncertainty in France that stalled non-urgent policymaking, the government has finally passed its 2026 budget , clearing a major hurdle for the long-anticipated rollout of a full medical cannabis framework . Our CEO, Benjamin Jeanroy , underscores why this matters: the budget paralysis had left France’s regulatory texts sitting complete but unsigned for months , slowing the transition from pilot programme to permanent system. With the fiscal bill now

Benjamin-Alexandre Jeanroy, CEO and co-founder of Augur Associates , will participate in the webcast ‘Medical Cannabis: A Model in the...

After a long summer break, the Global Cannabis Network Collective Business Podcast is back with a new episode diving into France’s...

France is laying the groundwork for the full integration of medical cannabis  into its national healthcare system, with a...

France may be taking a slower, more cautious path on medical cannabis, but that could be its biggest strength. As highlighted in a recent...

Augur Associates ' CEO, Benjamin-Alexandre Jeanroy, sheds light on the recent French medical cannabis regulatory announcements, which...

Augur Associates ' CEO Benjamin-Alexandre Jeanroy gave his perspective on the recent adult-use regulatory development and how...

In recent discussions about drug policy reform, the spotlight has increasingly focused on how European Union (EU) Member States navigate...